Filter
349
Filtered Results: 349
Text search:
N.
Nguyen
Featured
Recommendations
33
New Publications
47
Language
Document type
No document type
124
Studies & Reports
87
Guidelines
73
Manuals
30
Strategic & Response Plan
13
Fact sheets
10
Training Material
9
Situation Updates
1
Resource Platforms
1
Infographics
1
Countries / Regions
Global
23
Russia
14
Brazil
7
Vietnam
7
Ukraine
6
Latin America and the Carribbean
6
Africa
6
Germany
5
India
4
Nepal
4
Spain
4
Liberia
3
Ghana
3
South Africa
3
Malawi
3
Eastern Europe
3
France
3
Burkina Faso
2
Ethiopia
2
Philippines
2
Kenya
2
Thailand
2
Mozambique
2
Argentina
2
Colombia
2
Ecuador
2
Middle East and North Africa
2
Western and Central Europe
2
Portugal
2
Guinea
1
Sierra Leone
1
Congo, Democratic Republic of
1
Mali
1
USA
1
Cameroon
1
Uganda
1
Zimbabwe
1
Haiti
1
Pakistan
1
South Sudan
1
Turkey
1
Egypt
1
Tanzania
1
Cambodia
1
Rwanda
1
Indonesia
1
Bangladesh
1
Singapore
1
Benin
1
Angola
1
Madagascar
1
Myanmar / Burma
1
Chile
1
East and Southern Africa
1
West and Central Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Asia
1
Italy
1
Armenia
1
Southern Africa
1
Tajikistan
1
Kyrgyzstan
1
Kazakhstan
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
82
Clinical Guidelines
47
Public Health
28
Women & Child Health
18
Key Resources
8
Pharmacy & Technologies
4
Capacity Building
1
Toolboxes
COVID-19
63
HIV
48
TB
39
Mental Health
30
Planetary Health
23
Rapid Response
19
NCDs
15
AMR
9
Pharmacy
8
NTDs
8
Disability
7
Caregiver
7
Ebola
6
Global Health Education
5
Conflict
3
Natural Hazards
3
Refugee
1
Specific Hazards
1
Background paper 9
The Independent Panel for Pandemic Preparedness and Response
May 2021
Background paper 13
The Independent Panel for Pandemic Preparedness and Response
May 2021
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp...
Interim guidanceAnnex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
En el Plan estratégico de preparación y respuesta frente a la COVID-19, del 2021, la Organización Panamericana de la Salud invita a las autoridades nacionales a actualizar los planes nacionales para la COVID-19 a fin de incorporar las enseñanzas extraídas a lo largo del 2020, de prever los reto...
Published OnlineJuly 14, 2021https://doi.org/10.1016/S2214-109X(21)00164-9. New Lancet research offers the first comprehensive analysis of the growing footprint of noncommunicable and injury-related neurological disorders to India’s overall disease burden.
Takeaways from 1990 to 2019 In terms ...
The State of the world’s nursing 2020 report provides the latest, most up-to-date evidence on and policy options for the global nursing workforce.
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
Orientations provisoires 19 juillet 2021
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health coverage.
The road map will reinforce and combine with wider initiatives, such as those aimed at s...
La méningite est mortelle et débilitante ; elle frappe brutalement ; elle a de graves conséquences sanitaires, économiques et sociales et touche tous les âges de la vie dans tous les pays du monde. La méningite bactérienne peut être à l’origine d’épidémies, entraîner la mort dans les...
La meningitis es una enfermedad mortal y debilitante; golpea rápidamente, conlleva graves consecuencias sanitarias, económicas y sociales, y afecta a personas de todas las edades y en todos los países del mundo. La meningitis bacteriana puede provocar epidemias, ocasionar la muerte en 24 horas y ...
Dexametasona para tratamento de pacientes com COVID-19
The COVID-19 pandemic arrived in an evolving epidemiological context where some countries are experiencing a progressive decrease in HIV positivity in their testing programme as they are moving closer to the first 95 target. Distinguishing changes in HIV testing services due to the COVID-19 pandemic...
This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations about care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of a...
